Retractions Damage Scientists’ Reputations: Study

Authors of rescinded papers see a 10 percent to 20 percent decline in citation rates for their other publications.

Written byAggie Mika
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, KIZILKAYAPHOTOSLife science researchers who author retracted papers are perceived as less credible by their peers, according to a study published online last month (August 14) in Research Policy. On average, these scientists experienced a 10 percent dip in citations of their unaffected work following a retraction, the study finds. Meanwhile, prominent scientists—individuals who were highly cited or were raking in top funding at the time of the retraction—experienced a nearly 20 percent drop in citation rates.

“The mighty fall further, because they were standing taller to begin with,” coauthor Alessandro Bonatti of MIT Sloan School of Management says in a news release.

To understand how retractions affect the scientific community’s perception of researchers’ remaining publications, the authors of the current study examined citation rates for the bodies of work produced by both offending and retraction-free authors. The researchers assessed 23,620 publications by 376 scientists who had published papers between 1977 and 2007 that were later retracted. For their control group, the researchers also evaluated 46,538 publications, taken from in the same journals and written by 759 authors whose work had never been retracted.

“The question we’re asking is: Do retractions trigger, at an individual level, something like an infection mechanism, where ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies